Back to Search
DR. STUART L FELDMAN M.D.
M.D.
Urology Physician
NPI: 1508089707Individual
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
G41816(CA)
Research & Publications (20)
Commentary on 'Indoor tanning injuries: an evaluation of FDA adverse event reporting data'.
PMID 19614902·Photodermatol Photoimmunol Photomed·2009
8-other
The blood oxygen level-dependent functional MR imaging signal can be used to identify brain tumors and distinguish them from normal tissue.
PMID 19208905·AJNR Am J Neuroradiol·2009
8-other
Commentary: The relative ease of obtaining a dermatologic appointment in Boston: how methods drive results.
PMID 19467367·J Am Acad Dermatol·2009
8-other
Evaluating the AMIA-OHSU 10x10 program to train healthcare professionals in medical informatics.
PMID 18999199·AMIA Annu Symp Proc·2008
8-other
Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis.
PMID 18627375·Br J Dermatol·2008
4-observational
Looking beyond the borders of our specialty: the 2006 Clarence S. Livingood MD Lecture.
PMID 18319017·Dermatol Online J·2007
8-other
Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial.
PMID 18154220·Cutis·2007
3-trial
Evaluating the AMIA-OHSU 10x10 program to train health care professionals.
PMID 18694053·AMIA Annu Symp Proc·2007
8-other
Systemic therapy does not usually clear psoriasis, but treatment success does not require clearing.
PMID 15627096·J Am Acad Dermatol·2005
8-other
Involving the patient: impact of inflammatory skin disease and patient-focused care.
PMID 15968267·J Am Acad Dermatol·2005
6-review
Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
PMID 15888152·Br J Dermatol·2005
3-trial
Decision points for the initiation of systemic treatment for psoriasis.
PMID 15965429·J Am Acad Dermatol·2005
6-review
Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trial.
PMID 16243150·J Am Acad Dermatol·2005
3-trial
Improved health-related quality of life following a randomized controlled trial of alefacept treatment in patients with chronic plaque psoriasis.
PMID 14996104·Br J Dermatol·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1950 SUNNYCREST DR, #3400
FULLERTON, CA 92835 - Phone
- (714) 879-2410
Quick Facts
- NPI
- 1508089707
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile